Bufexamac
丁苯羟酸
Report date: 2023/03/21 20:00:39
NME
Base Information
Drug NameBufexamac
Drug Alias Name +[8]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A
Develop Information
Active CompaniesHunan Dino Pharmaceutical Co Ltd
Inactive CompaniesHoechst Marion Roussel Ltd
Active Indications
Inactive IndicationsN/A